Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company, today announced that Jonathan Goodman, President and CEO, will present a corporate update at the UBS Global Specialty Pharmaceuticals Conference on Monday, April 24, 2006, at 1:30 p.m. ET, at The Grand Hyatt hotel in New York City.
